Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bazan

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
The EMBO Journal|November 9, 2007
Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF bindingBrent A Appleton, Ping Wu, Janice Maloney, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
"Design principles of a membrane-spanning ubiquitin ligase"Carys Williams, Laura M Nocka, George Hedger, et al.
JAMA Oncology|May 13, 2022
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical TrialPierre Heudel, Jean-Sébastien Frenel, Cécile Dalban, et al.
Cancers|March 14, 2026
Germline <i>BRCA1/2</i> Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in FranceGuillaume Meynard, Victor Pereira, Sophie Paget-Bailly, et al.
Frontiers in Oncology|August 5, 2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL StudyMagali Rebucci-Peixoto, Angélique Vienot, Olivier Adotevi, et al.
BMJ Supportive & Palliative Care|December 31, 2024
Postcancer rehabilitation: multidisciplinary exercise - programme organisation and feasibilityChloé Drozd, Quentin Jacquinot, Sophie Paget-Bailly, et al.
Molecular Cell|May 26, 2026
Design principles of a membrane-spanning ubiquitin ligaseCarys Williams, Laura M Nocka, George Hedger, et al.
Nature Immunology|June 11, 2002
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLPVassili Soumelis, Pedro A Reche, Holger Kanzler, et al.
Molecular Oncology|November 12, 2022
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO groupNour-El-Houda Mourksi, Cécile Dalban, Amélie Colombe-Vermorel, et al.
Science (New York, N.Y.)|September 4, 2009
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaRobert L Yauch, Gerrit J P Dijkgraaf, Bruno Alicke, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
The EMBO Journal|November 9, 2007
Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF bindingBrent A Appleton, Ping Wu, Janice Maloney, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
"Design principles of a membrane-spanning ubiquitin ligase"Carys Williams, Laura M Nocka, George Hedger, et al.
JAMA Oncology|May 13, 2022
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical TrialPierre Heudel, Jean-Sébastien Frenel, Cécile Dalban, et al.
Cancers|March 14, 2026
Germline <i>BRCA1/2</i> Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in FranceGuillaume Meynard, Victor Pereira, Sophie Paget-Bailly, et al.
Frontiers in Oncology|August 5, 2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL StudyMagali Rebucci-Peixoto, Angélique Vienot, Olivier Adotevi, et al.
BMJ Supportive & Palliative Care|December 31, 2024
Postcancer rehabilitation: multidisciplinary exercise - programme organisation and feasibilityChloé Drozd, Quentin Jacquinot, Sophie Paget-Bailly, et al.
Molecular Cell|May 26, 2026
Design principles of a membrane-spanning ubiquitin ligaseCarys Williams, Laura M Nocka, George Hedger, et al.
Nature Immunology|June 11, 2002
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLPVassili Soumelis, Pedro A Reche, Holger Kanzler, et al.
Molecular Oncology|November 12, 2022
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO groupNour-El-Houda Mourksi, Cécile Dalban, Amélie Colombe-Vermorel, et al.
Science (New York, N.Y.)|September 4, 2009
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaRobert L Yauch, Gerrit J P Dijkgraaf, Bruno Alicke, et al.
Pageof 11